Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Clinical Rheumatology|March 1, 1994
CD4+ and CD8+ subsets: naive and memory cells in the peripheral blood of patients with systemic sclerosisR Gorla, P Airò, A Malagoli, et al.
Clinical and Experimental Rheumatology|January 17, 2014
Reduction of peripheral blood T cells producing IFN-γ and IL-17 after therapy with abatacept for rheumatoid arthritisM Scarsi, C Zanotti, M Chiarini, et al.
Toxicology Letters|April 20, 2004
Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancyR Cimaz, E Meregalli, M Biggioggero, et al.
Lupus|March 25, 2015
Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin DS Piantoni, L Andreoli, M Scarsi, et al.
Clinical and Experimental Rheumatology|October 16, 2004
Intravenous cyclophosphamide therapy for systemic sclerosis. A single-center experience and review of the literature with pooled analysis of lung function test resultsP Airò, E Danieli, G Parrinello, et al.
Advances in Experimental Medicine and Biology|December 22, 1999
Chilblain lupus erythematosus is associated with antibodies to SSA/RoF Franceschini, P Calzavara-Pinton, L Valsecchi, et al.
Bone Marrow Transplantation|April 1, 1999
Immune reconstitution after bone marrow transplantation for combined immunodeficiencies: down-modulation of Bcl-2 and high expression of CD95/Fas account for increased susceptibility to spontaneous and activation-induced lymphocyte cell deathD Brugnoni, P Airò, M Pennacchio, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|November 1, 1996
CD4+ cells from patients with Common Variable Immunodeficiency have a reduced ability of CD40 ligand membrane expression after in vitro stimulationD Brugnoni, P Airò, M Lebovitz, et al.
Clinical and Experimental Rheumatology|June 5, 2007
Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phaseP Airò, E Danieli, M Rossi, et al.
European Journal of Pediatrics|November 1, 1992
Insulin-dependent diabetes mellitus and severe atopic dermatitis in a child with adenosine deaminase deficiencyL D Notarangelo, G Stoppoloni, R Toraldo, et al.
Pageof 6